UCLA researchers develop MAESTRO AI platform to identify cancer drug combinations
UCLA investigators have created MAESTRO, an artificial intelligence platform that uses large language models to analyze scientific knowledge and identify promising drug combinations to overcome treatment resistance in cancer. The platform was described in the journal Advanced Science.
